← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The Medical University Of South Carolina
$83,326,796
Total funding
82
Grants
Funding over time
peak $20M · FY2008–25$25M$18.8M$12.5M$6.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$76,958,263 · 75
DOE$5,114,320 · 5
NASA$1,254,213 · 2
By mechanism
—$83,326,796 · 82
Investigators at The Medical University Of South Carolina
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
SOUTHEASTERN VIRTUAL INSTITUTE FOR HEALTH EQUITY AND WELLNESS (SE VIEW)$12,737,000
· FY2010 · Department of Defense
SOUTHEASTERN VIRTUAL INSTITUTE FOR HEALTH EQUITY AND WELLNESS, PHASE TWO$6,991,000
· FY2011 · Department of Defense
ELECTROALCOHOLGENESIS: BIOELECTROCHEMICAL REDUCTION OF CO2 TO BUTANOL$4,975,282
· FY2010 · Department of Energy
"REDUCTION IN SUICIDE RISK: A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF OMEGA-3 FATTY ACID SUPPLEMENTATION AMONG MILITARY VETERANS"$4,269,809
· FY2013 · Department of the Army
INCREASING TREATMENT SEEKING AMONG AT-RISK SERVICE MEMBERS RETURNING FROM WARZONES$2,327,585
· FY2013 · Department of the Army
OSTEOCLAST INHIBITORY PEPTIDE-1 THERAPY FOR PAGET'S DISEASE$2,285,014
· FY2009 · Department of Defense
PEER SOCIAL SUPPORT DURING IN VIVO EXPOSURE FOR PTSD: A PROGRAM TO ADDRESS DROPOUT FROM PROLONGED EXPOSURE$2,112,716
· FY2018 · Department of the Army
DO YOU REALLY EXPECT ME TO GET MST CARE IN A VA WHERE EVERYONE IS MALE? INNOVATIVE DELIVERY OF EVIDENCE-BASED PSYCHOTHERAPY TO WOMEN WITH MILITARY SE$2,064,315
· FY2014 · Department of Defense
PANCREATIC ENDOTHERAPY FOR REFRACTORY CHRONIC PANCREATITIS$1,953,219
· FY2019 · Defense Health Agency
TARGETING DRUG RESISTANCE IN THE BONE MICROENVIRONMENT USING A NOVEL PIM-PROTAC$1,791,407
· FY2025 · Defense Health Agency
DEVELOPMENT OF TOPICAL TREATMENT FOR PESEUDOMONAS AERUGINOSA WOUND INFECTIONS$1,696,365
· FY2012 · Department of the Army
ARIH1 FUNCTION IN EMT AND TUMORIGENESIS$1,503,880
· FY2022 · Department of the Army
UNDERSTANDING, PREDICTING, AND PREVENTING LIFE-CHANGING AND LIFE-THREATENING HEALTH CHANGES AMONG AGING VETERANS AND CIVILIANS WITH SPINAL CORD INJUR$1,494,420
· FY2016 · Department of the Army
GLYCOSPHINGOLIPIDS AS THERAPEUTIC TARGETS AND BIOMARKERS OF LUPUS NEPHRITIS$1,400,276
· FY2016 · Department of the Army
MUSC/BAYLOR BRIDGE PROGRAM$1,298,590
· FY2011 · Department of Defense
EXPLOIT IMMUNE SIGNATURES FROM IMMUNOTHERAPY RESPONSE IN METASTATIC RENAL CELL CANCER TO IMPROVE QUALITY OF LIFE AND SURVIVAL OF VETERANS$1,185,996
· FY2025 · Defense Health Agency
DEVELOPMENT OF NOVEL MOLECULARY TARGETED THERAPY TO SECRETED FRIZZLED RELATED PROTEIN 2 FOR BREAST CANCER$1,134,621
· FY2018 · Department of the Army
ROLE OF TRNAS IN BREAST CANCER TUMOR PROGRESSION$1,118,883
· FY2019 · Defense Health Agency
OVERCOMING RESISTANCE TO INHIBITORS OF THE AKT PROTEIN KINASE BY MODULATION OF THE PIM KINASE PATHWAY$1,106,248
· FY2012 · Department of Defense
EXTRACELLULAR HSP90 AS A NOVEL EPIGENETIC REGULATOR OF EMT AND METASTATIC RISK IN PROSTATE CANCER$1,106,194
· FY2012 · Department of the Army